KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Treasury Shares: 2021-2025

Historic Treasury Shares for Rigel Pharmaceuticals (RIGL) over the last 4 years, with Sep 2025 value amounting to $569,106.

  • Rigel Pharmaceuticals' Treasury Shares rose 51.73% to $569,106 in Q3 2025 from the same period last year, while for Sep 2025 it was $569,106, marking a year-over-year increase of 51.73%. This contributed to the annual value of $387,282 for FY2024, which is 108.29% up from last year.
  • As of Q3 2025, Rigel Pharmaceuticals' Treasury Shares stood at $569,106, which was up 0.58% from $565,846 recorded in Q2 2025.
  • In the past 5 years, Rigel Pharmaceuticals' Treasury Shares ranged from a high of $4.1 million in Q1 2024 and a low of $185,938 during Q4 2023.
  • In the last 3 years, Rigel Pharmaceuticals' Treasury Shares had a median value of $568,024 in 2025 and averaged $1.2 million.
  • As far as peak fluctuations go, Rigel Pharmaceuticals' Treasury Shares surged by 387.80% in 2022, and later plummeted by 86.05% in 2025.
  • Quarterly analysis of 5 years shows Rigel Pharmaceuticals' Treasury Shares stood at $226,250 in 2021, then spiked by 387.80% to $1.1 million in 2022, then tumbled by 83.15% to $185,938 in 2023, then surged by 108.29% to $387,282 in 2024, then skyrocketed by 51.73% to $569,106 in 2025.
  • Its Treasury Shares was $569,106 in Q3 2025, compared to $565,846 in Q2 2025 and $568,024 in Q1 2025.